FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W815218822> ?p ?o ?g. }

• W815218822 endingPage "1682" @default.
• W815218822 startingPage "1682" @default.
• W815218822 abstract "Abstract Introduction T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-Cell malignancy typically associated with aggressive clinical course. Leukemic T-cells demonstrate post-thymic T-cell phenotypes (Tdt-, CD1a-, CD5+, CD2+ and CD7+) and commonly are CD4+/CD8- T-cells, but co-expression of CD4+/CD8+ or CD8+/CD4- have also been observed. Rearrangement of chromosome 14 involving TCL1 locus is the cornerstone for T-PLL diagnosis which leads to overexpression of oncogene TCL1. As a binding partner for TCL1, AKT expression correlates with worse prognosis. Despite advances in identification of novel mutations, therapeutic option is limited with most patients having very short survival. Herein, we performed a detailed analysis of specific T-cell subsets affected in T-PLL and a comprehensive genomic analysis by whole exome sequencing (WES) and RNA sequencing. We also explored the preclinical efficacy of targeting AKT activation by AKT inhibitor MK2206 on leukemic T-cells isolated from T-PLL patients. Methods T-PLL leukemic cells were isolated from blood or marrow samples of T-PLL patients (n=9) and were tested for involved T-cell subsets by multicolor flow cytometric analysis. Leukemic T-cells were treated with escalating doses of MK2206 (0 to 10 µM) for about 80 hours and were assessed for their apoptosis levels using Annexin V flow cytometric analysis. Whole exome sequencing (WES) and RNA sequencing were conducted using genomic DNA and RNA isolated from purified leukemic T cells from T-PLL patients. Results Phenotypic analysis of T-cell subsets in T-PLL patients showed that leukemic T-cells in 4 untreated T-PLL patients are consistent with naïve T-cell phenotype (CD45RA+, CD45RO-, CCR7+). Leukemic T-cells in 3 of the untreated patients and in 2 of the treated patients have central memory T (CD45RA-, CD45RO+, CCR7+) and effector memory T phenotypes (CD45RA-, CD45RO+,CCR7-) respectively. MK2206 treatment was able to induce dose-dependent apoptosis on the isolated PBMC (containing > 90% leukemic T-cells) of T-PLL patients (n=4) (IC50: 5 µM). FISH analysis found a rearrangement of TCL1 locus on chromosome 14 in all T-PLL cases (n=9). Three cases have also been detected to have del (11q) involving ATM locus and one patient has both del(11q) and del(17p). Subsequent WES (n=7) and RNA sequencing (n=6) analysis revealed recently reported mutations in ATM (frame shift mutation and early stop mutation W579*) in 2 cases, JAK3 (M511I) in 2 cases and STAT5B (T628S and N642H) in 2 cases. Importantly, novel somatic mutations in gene IKZF1 (N159S), NTRK1 (R33W), AP2A2 (P514L), HDAC8 (I115R), RARB (G90W) and TNIP2 (K104Q) were detected by WES. Mutations in EML4 (L548W and F304S) and VAV3 (C282Y and splice site mutation) were also identified in 2 different T-PLL cases. RNA sequencing revealed several fusion transcripts resulting in early stop of several different genes including PTPRT, L3MBTL1, UCKL1 in one T-PLL case. Conclusion T-PLL leukemic T-cells are consistent with either naïve or central memory T-cell subsets in untreated patients. The AKT inhibitor MK-2206 was capable of inducing apoptosis and could be a potential therapeutic agent for T-PLL patients. In addition, we detected known mutations in ATM and JAK-STAT pathways. Novel mutations in genes involving DNA binding and chromatin remodeling (IKZF1, HDAC8) or kinase signal pathway (NTRK1, TNIP2, VAV3, EML4) were uncovered. These results suggest that further therapeutic approaches could be developed to target DNA binding factors or JAK-STAT or AKT-TCL1 signal pathway with an ultimate goal to improve survival of T-PLL patients. Disclosures Off Label Use: Off label use of MK2206: MK-2206 is an AKT inhibitor obtained from Selleck Chemicals and is used to treat leukemic cells in vitro to test the leukemic sensitivity to AKT inhibition. ." @default.
• W815218822 created "2016-06-24" @default.
• W815218822 creator A5004152557 @default.
• W815218822 creator A5007075478 @default.
• W815218822 creator A5009747339 @default.
• W815218822 creator A5036129605 @default.
• W815218822 creator A5041539604 @default.
• W815218822 creator A5049144598 @default.
• W815218822 creator A5051752737 @default.
• W815218822 creator A5072463255 @default.
• W815218822 creator A5075005037 @default.
• W815218822 creator A5076621021 @default.
• W815218822 creator A5082845313 @default.
• W815218822 creator A5090406453 @default.
• W815218822 creator A5090694142 @default.
• W815218822 date "2014-12-06" @default.
• W815218822 modified "2023-09-28" @default.
• W815218822 title "Novel Phenotypic and Genetic Analysis of T-Cell Prolymphocytic Leukemia (T-PLL)" @default.
• W815218822 doi "https://doi.org/10.1182/blood.v124.21.1682.1682" @default.
• W815218822 hasPublicationYear "2014" @default.
• W815218822 type Work @default.
• W815218822 sameAs 815218822 @default.
• W815218822 citedByCount "3" @default.
• W815218822 countsByYear W8152188222015 @default.
• W815218822 countsByYear W8152188222017 @default.
• W815218822 countsByYear W8152188222021 @default.
• W815218822 crossrefType "journal-article" @default.
• W815218822 hasAuthorship W815218822A5004152557 @default.
• W815218822 hasAuthorship W815218822A5007075478 @default.
• W815218822 hasAuthorship W815218822A5009747339 @default.
• W815218822 hasAuthorship W815218822A5036129605 @default.
• W815218822 hasAuthorship W815218822A5041539604 @default.
• W815218822 hasAuthorship W815218822A5049144598 @default.
• W815218822 hasAuthorship W815218822A5051752737 @default.
• W815218822 hasAuthorship W815218822A5072463255 @default.
• W815218822 hasAuthorship W815218822A5075005037 @default.
• W815218822 hasAuthorship W815218822A5076621021 @default.
• W815218822 hasAuthorship W815218822A5082845313 @default.
• W815218822 hasAuthorship W815218822A5090406453 @default.
• W815218822 hasAuthorship W815218822A5090694142 @default.
• W815218822 hasConcept C104317684 @default.
• W815218822 hasConcept C127716648 @default.
• W815218822 hasConcept C147483822 @default.
• W815218822 hasConcept C153911025 @default.
• W815218822 hasConcept C154317977 @default.
• W815218822 hasConcept C16671776 @default.
• W815218822 hasConcept C167672396 @default.
• W815218822 hasConcept C202751555 @default.
• W815218822 hasConcept C203014093 @default.
• W815218822 hasConcept C2775983024 @default.
• W815218822 hasConcept C2776090121 @default.
• W815218822 hasConcept C2777938653 @default.
• W815218822 hasConcept C2778461978 @default.
• W815218822 hasConcept C502942594 @default.
• W815218822 hasConcept C54355233 @default.
• W815218822 hasConcept C86803240 @default.
• W815218822 hasConcept C8891405 @default.
• W815218822 hasConceptScore W815218822C104317684 @default.
• W815218822 hasConceptScore W815218822C127716648 @default.
• W815218822 hasConceptScore W815218822C147483822 @default.
• W815218822 hasConceptScore W815218822C153911025 @default.
• W815218822 hasConceptScore W815218822C154317977 @default.
• W815218822 hasConceptScore W815218822C16671776 @default.
• W815218822 hasConceptScore W815218822C167672396 @default.
• W815218822 hasConceptScore W815218822C202751555 @default.
• W815218822 hasConceptScore W815218822C203014093 @default.
• W815218822 hasConceptScore W815218822C2775983024 @default.
• W815218822 hasConceptScore W815218822C2776090121 @default.
• W815218822 hasConceptScore W815218822C2777938653 @default.
• W815218822 hasConceptScore W815218822C2778461978 @default.
• W815218822 hasConceptScore W815218822C502942594 @default.
• W815218822 hasConceptScore W815218822C54355233 @default.
• W815218822 hasConceptScore W815218822C86803240 @default.
• W815218822 hasConceptScore W815218822C8891405 @default.
• W815218822 hasIssue "21" @default.
• W815218822 hasLocation W8152188221 @default.
• W815218822 hasOpenAccess W815218822 @default.
• W815218822 hasPrimaryLocation W8152188221 @default.
• W815218822 hasRelatedWork W1505145311 @default.
• W815218822 hasRelatedWork W1513178816 @default.
• W815218822 hasRelatedWork W1516968396 @default.
• W815218822 hasRelatedWork W2052937977 @default.
• W815218822 hasRelatedWork W2081704009 @default.
• W815218822 hasRelatedWork W2153742280 @default.
• W815218822 hasRelatedWork W2185890143 @default.
• W815218822 hasRelatedWork W2287738525 @default.
• W815218822 hasRelatedWork W4285891189 @default.
• W815218822 hasRelatedWork W2181857777 @default.
• W815218822 hasVolume "124" @default.
• W815218822 isParatext "false" @default.
• W815218822 isRetracted "false" @default.
• W815218822 magId "815218822" @default.
• W815218822 workType "article" @default.